Help us: Donate
Follow us on:



Lifespan News – A New Senolytic Enters Human Trials

Lifespan News on Anti-Aging DrugsLifespan News on Anti-Aging Drugs

On Lifespan News this week, Brent Nally discusses skin regeneration, senolytics in human trials, T cell progenitors that boost the effectiveness of stem cell therapies, antibodies for glucosepane, and big pharma attempting to discover more senolytic drugs.

Further Reading

Regenerating Skin With a Single Protein

A New Senolytic Enters Human Trials

T Cell Progenitors Boost Stem Cell Therapy Effectiveness

Creating Anti-Glucosepane Antibodies

Big pharma enters senolytic drug discovery program

Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension: YouTube Facebook Twitter Instagram Instagram Discord
Thank You!

CategoryLifespan News, News
No Comments
Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.